Sleep Apnea Syndrome and Vitamin D
Effect of the Correction of Vitamin D Deficiency in Patients With Obstructive Sleep Apnea-hypopopnea Syndrome (OSAHS)
Sponsor: Centre de Recherche en Nutrition Humaine Rhone-Alpe
Listed as NCT01323218, this PHASE2 trial focuses on Obstructive Sleep Apnea-hypopnea Syndrome and remains ongoing. Sponsored by Centre de Recherche en Nutrition Humaine Rhone-Alpe, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Mar 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre de Recherche en Nutrition Humaine Rhone-Alpe
- Centre de Recherche en Nutrition Humaine d'Auvergne
- Laboratoire Cidelec
- Laboratoire Crinex
- University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .